Chloe Yang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chloe Yang

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Blood Cancer Discovery|March 11, 2026

Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple MyelomaRintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.

Blood Advances|January 16, 2026

Improved survival and healthcare utilization with CAR-T vs historical care in relapsed-refractory large B-cell lymphomaTiana Kordbacheh, Kelvin Kw Chan, Michael Crump, et al.

Blood Neoplasia|October 28, 2025

Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapyChathuri Abeyakoon, Sita Bhella, Katrina Hueniken, et al.

Hematological Oncology|March 3, 2026

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR TInna Y Gong, Meenakshi Jeeva, Katrina Hueniken, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Blood Cancer Discovery|March 11, 2026

Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple MyelomaRintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.

Blood Advances|January 16, 2026

Improved survival and healthcare utilization with CAR-T vs historical care in relapsed-refractory large B-cell lymphomaTiana Kordbacheh, Kelvin Kw Chan, Michael Crump, et al.

Blood Neoplasia|October 28, 2025

Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapyChathuri Abeyakoon, Sita Bhella, Katrina Hueniken, et al.

Hematological Oncology|March 3, 2026

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR TInna Y Gong, Meenakshi Jeeva, Katrina Hueniken, et al.

Pageof 2